Robust passive and active efflux of cellular cholesterol to a designer functional mimic of high density lipoprotein

Autor: Michael C. Phillips, Chad A. Mirkin, Daniel J. Rader, Duyen Quach, C. Shad Thaxton, Nicholas N. Lyssenko, Kasey C. Vickers, John S. Millar, Andrea J. Luthi, Kaylin M. McMahon
Jazyk: angličtina
Rok vydání: 2015
Předmět:
ATP-binding cassette transporter G1
Cardiotonic Agents
Lipoproteins
Phospholipid
Drug Evaluation
Preclinical

QD415-436
ATP-binding cassette transporter A1
Coronary Artery Disease
030204 cardiovascular system & hematology
Biology
Biochemistry
Cell Line
03 medical and health sciences
chemistry.chemical_compound
0302 clinical medicine
Endocrinology
High-density lipoprotein
Drug Stability
scavenger receptor class B type I
Cricetinae
Animals
Scavenger receptor
Research Articles
Phospholipids
030304 developmental biology
ATP Binding Cassette Transporter
Subfamily G
Member 1

0303 health sciences
Apolipoprotein A-I
Cholesterol
Macrophages
Molecular Mimicry
Biological Transport
Cell Biology
Scavenger Receptors
Class B

ATP Binding Cassette Transporter 1
chemistry
ABCG1
ABCA1
biology.protein
Nanoparticles
lipids (amino acids
peptides
and proteins)

ATP-Binding Cassette Transporters
Efflux
Gold
atherosclerosis
cholesterol efflux
Zdroj: Journal of Lipid Research
Journal of Lipid Research, Vol 56, Iss 5, Pp 972-985 (2015)
ISSN: 1539-7262
0022-2275
Popis: The ability of HDL to support macrophage cholesterol efflux is an integral part of its atheroprotective action. Augmenting this ability, especially when HDL cholesterol efflux capacity from macrophages is poor, represents a promising therapeutic strategy. One approach to enhancing macrophage cholesterol efflux is infusing blood with HDL mimics. Previously, we reported the synthesis of a functional mimic of HDL (fmHDL) that consists of a gold nanoparticle template, a phospholipid bilayer, and apo A-I. In this work, we characterize the ability of fmHDL to support the well-established pathways of cellular cholesterol efflux from model cell lines and primary macrophages. fmHDL received cell cholesterol by unmediated (aqueous) and ABCG1- and scavenger receptor class B type I (SR-BI)-mediated diffusion. Furthermore, the fmHDL holoparticle accepted cholesterol and phospholipid by the ABCA1 pathway. These results demonstrate that fmHDL supports all the cholesterol efflux pathways available to native HDL and thus, represents a promising infusible therapeutic for enhancing macrophage cholesterol efflux. fmHDL accepts cholesterol from cells by all known pathways of cholesterol efflux: unmediated, ABCG1- and SR-BI-mediated diffusion, and through ABCA1.
Databáze: OpenAIRE